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ABSTRACT
Objective: To correlate arrhythmic symptoms with the presence of 
significant arrhythmias through the external event monitoring (web-
loop). Methods: Between January and December 2011, the web-
loop was connected to 112 patients (46% of them were women, 
mean age 52±21 years old). Specific arrhythmic symptoms were 
defined as palpitations, pre-syncope and syncope observed during the 
monitoring. Supraventricular tachycardia, atrial flutter or fibrillation, 
ventricular tachycardia, pauses greater than 2 seconds or advanced 
atrioventricular block were classified as significant arrhythmia. The 
association between symptoms and significant arrhythmias were 
analyzed. Results: The web-loop recorded arrhythmic symptoms in 
74 (66%) patients. Of these, in only 14 (19%) patients the association 
between symptoms and significant cardiac arrhythmia was detected. 
Moreover, significant arrhythmia was found in 11 (9.8%) asymptomatic 
patients. There was no association between presence of major symptoms 
and significant cardiac arrhythmia (OR=0.57, CI95%: 0.21-1.57; p=0.23). 
Conclusion: We found no association between major symptoms and 
significant cardiac arrhythmia in patients submitted to event recorder 
monitoring. Event loop recorder was useful to elucidate cases of 
palpitations and syncope in symptomatic patients.
Keywords: Monitoring, physiologic/instrumentation; Monitoring, physiologic/ 
methods; Arrhythmias, cardiac/diagnosis; Syncope
RESUMO
Objetivo: Correlacionar sintomas arrítmicos com a presença de 
arritmias significativas por meio do monitor de eventos externo 
(web-loop). Métodos: Entre janeiro e dezembro de 2011, o web-loop foi 
instalado em 112 pacientes (46% mulheres, 52±21 anos). Sintomas 
específicos foram definidos como palpitação, pré-síncope e síncope, 
presentes durante a monitorização. Arritmia significativa foi definida 
como taquicardia paroxística supraventricular, flutter e fibrilação atrial, 
taquicardia ventricular, pausas superiores a 2 segundos ou bloqueio 
atrioventricular avançado. A associação entre presença de sintomas e 
arritmias significativas foi avaliada. Resultados: O monitor de eventos 
registrou sintomas específicos em 74 (66%) pacientes, entretanto 
a associação entre sintomas específicos e arritmia significativa foi 
observada em apenas 14 (19%) deles. Em 11 pacientes (9,8%), foi 
detectada arritmia significativa na ausência de sintomas. Não houve 
associação entre a presença de sintomas e a detecção de arritmia 
significativa (OR=0,57, IC95%: 0,21-1,57; p=0,23). Conclusão: Em 
pacientes monitorizados pelo web-loop, não houve associação entre a 
presença de sintomas específicos e a detecção de arritmias significativas. 
O monitor de eventos pode ter importância na elucidação de sintomas de 
palpitações e síncope dos pacientes.
Descritores: Monitorização fisiológica/instrumentação; Monitorização 
fisiológica/métodos; Arritmias cardíacas/diagnóstico; Síncope
INTRODUCTION
Palpitations, dizziness, pre-syncope and syncope are 
common complaints in physicians’ offices that might be 
related to cardiac arrhythmias. In some patients these 
symptoms can be triggered by stress and anxiety, but 
not associated with rhythmic disorders. The diagnosis 
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and adequate treatment depend on electrocardiographic 
record during symptoms occurrence. However, this record 
is not always easy and in case of sporadic symptoms, 
the continuous electrocardiogram (ECG) record for 24 
hours (Holter) might not be efficient.(1) 
External event monitor is a device that records ECG 
intermittently when activated. It increases the accuracy 
of diagnosis when symptoms occur less frequently, i.e., 
weekly, monthly or yearly.(2)
The correlation of arrhythmic symptoms and 
electrocardiographic record of significant arrhythmias 
using external events monitoring, which is known as 
web-loop, is still not determined in our population.
OBjECTIvE
To assess the association between specific symptoms 
(palpitations, pre-syncope and syncope) and identification 
of clinically significant arrhythmias through the web-loop, 
which is a specific type of external event monitor.
METHODS
Between January and December 2011 we revised exams 
of 112 patients who received an external event monitor 
at an arrhythmia center in Morumbi and Ibirapuera 
unit of the Hospital Israelita Albert Einstein. This study 
was approved by the ethical and Research Committee 
(CAAE: 14097413.3.0000.0071) and the consent form 
was waived because it was a retrospective study. 
External event monitor used was the Web Loop 
CW-10 (CardioWEB, São Paulo, Brazil). The device was 
connected to patient’s chest using two cables to collect 
the electrocardiographic sign. Patients were advised to 
keep the device as much as possible, removing it only 
to shower. 
Web-loop system collected and transmitted automatically 
the electrocardiographic sign for 15 seconds every each 
60 minutes. When the patient had symptoms such as 
palpitations, pre-syncope and syncope he/she would 
press the record button located at the bottom of the 
device. Another electrocardiographic record was also 
transmitted but lasting for 45 seconds, and 15 of them 
were recorded immediate before the system activation. 
Tracings were transmitted automatically using a GSM 
system (mobile signal) and a provider made available 
parts of the ECG collected through an internet homepage 
(https://looper.ecgweb.com.br).
Tracings transmitted were checked daily by the 
nursing team whose always called the patient when an 
event was recorded voluntary, and symptoms reported 
by the patient were documented. Medical team assessed 
tracings transmitted periodically and documented the 
electrocardiographic diagnosis. Standard duration of 
monitoring was 10 days, but when necessary it was stopped 
prematurely, and in case of significant arrhythmia record or 
if requested by the physician the monitoring was prolonged. 
Specific symptoms were defined as palpitations, pre-
syncope or syncope presented during monitoring. 
Significant arrhythmias were defined as paroxysmal 
supraventricular tachycardia, atrial flutter, atrial fibrillation, 
ventricular tachycardia, both supported (more than 
30 seconds of length) and non-supported, besides pauses 
greater than 2 seconds or second and third degree 
atrioventricular block. Symptomatic arrhythmias were 
defined as any arrhythmia along with symptoms (significant, 
but also supraventricular and ventricular extrasystoles, 
isolated or matched). 
Continuous variables were described in means ± 
standard deviations, and categorical variables were 
described in absolute and relative frequencies. The χ2 
test was used to assess association between presence 
of symptoms and significant arrhythmias. P<0.05 was 
considered as statistically significant. 
RESULTS
Of 112 patients who were assessed, 46% (n=51) were 
women. Patients’ mean age was 52±21 years with 
absolute values ranging between 13 days of life and 90 
years (Table 1). 
Table 1. Demographic characteristics of population monitored using the event 
monitor
Clinical characteristics Results
Age, years 52±21
Women, n (%) 51 (46)
Systemic arterial hypertension, n (%) 33 (29.5)
Diabetes mellitus, n (%) 7 (6.2)
Previous myocardial infarction, n (%) 0
Previous stroke, n (%) 3 (2.7)
The event monitor was activated to record 118 events 
(each patient had more than one symptomatic event). 
In these 118 events, more frequent symptoms were 
palpitations (49.1%), followed by dizziness, pre-syncope 
and syncope (24.6%). Non-arrhythmic symptoms such as 
chest pain and dyspnea were seen in 26.3% of cases. 
Among rhythm alterations detected, arrhythmias found 
were ventricular extrasystoles (n=46; 63.9%), atrial flutter 
and atrial fibrillation (n=13; 18.1%), pauses and second 
and third degree atrioventricular blocks (n=9; 12.5%) and 
supraventricular paroxysmal tachycardia (n=4; 5.5%), as 
shown in figure 1. 
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PSVT: paroxysmal supraventricular tachycardia; AF: atrial fibrillation; AFL: atrial flutter; VT: ventricular tachycardia; AAB: 
advan ced atrioventricular block.
Figure 1. Types of arrhythmias detected through the event monitor
Figure 2. Tracing of web-loop during palpitation (diagnosis of atrial 
fibrillation) in a 57-year-old man. Red tracing represents symptoms record 
in electrocardiographic derivation at the moment of system activation 
(during 45 seconds). Blue tracing are automatic and periodic emissions of 
electrocardiogram in a derivation (lasting 15 seconds each)
PSVT: paroxysmal supraventricular tachycardia; AF: atrial fibrillation; AFL: atrial flutter.
Figure 3. Types of rhythms and/or arrhythmias found according to each specific 
symptom reported
Palpitation was the most frequent symptom along 
with supraventricular and ventricular ectopics (n=27; 
47%). The most detected significant arrhythmias during 
complaints of “palpitations” were atrial flutter and atrial 
fibrillation (n=6; 10.3%), as shown in figure 2. Symptoms 
as syncope, pre-syncope and dizziness occurred both during 
ventricular and supraventricular extrasystoles records 
(n=7; 24.1%), as well as in sinus tachycardia (n=5; 17.2%). 
Significant arrhythmias was most commonly detected 
in patients with symptoms of syncope, pre-syncope and 
dizziness as well as atrial flutter and atrial fibrillation 
(n=3; 10.3%), as shown in figure 3. 
In 11 patients (9.8%) when there was no symptoms, 
the significant arrhythmia was detected – atrial flutter and 
atrial fibrillation (n=5), pauses (n=4) and supraventricular 
paroxysmal tachycardia (n=2). 
Specific symptoms (palpitations, pre-syncope and 
syncope) were seen in 74 (66%) of monitored patients. 
However, the association between specific symptoms 
and significant arrhythmia was observed in only 14 
patients (19%) (Table 2). There was no association 
Table 2. Result of significant arrhythmia detection by events monitor
Specific 
symptoms
Significant 
arrhythmia n (%)
Significant without 
arrhythmia n (%)
Total 
n (%)
Presented symptoms 14 (12.5) 60 (53.5) 74 (66)
Absent symptoms 11 (9.8) 27 (24.2) 38 (34)
Total 25 (22.3) 87(77.7) 112 (100)
between presence of symptoms and detection of significant 
arrhythmia (OR=0.57, confidence interval of 95% - CI 
95%: 0.21-1, 57: p=0.23). 
DISCUSSION
Palpitations are responsible for 16% of complaints in 
physicians’ offices.(3) The cardiac etiology is responsible 
for 43% of complaints, whereas psychiatric causes is 
responsible for 31% of cases.(4) The correlation between 
symptom and tracing is essential to understand’ etiology 
of symptoms, so that long-term electrocardiographic 
monitoring appears as a diagnostic option. 
Among clinical disease that lead patients to seek 
immediate health care, syncope is responsible to about 
3% of admission at emergency service and about 1% 
of hospital admissions.(5) Because mortality rate of 
syncope can reach up to 33% within one year in patients 
with structural heart disease,(6) the adequate diagnostic 
clarification is fundamental and for this reason, exams 
such as ECG, echocardiography, effort test and 24-hour 
electrocardiography record (Holter) are recommended 
as the first steps.(2)
However, palpitations, syncope and pre-syncope 
of sporadic occurrence can be difficult to diagnose 
and also can lead to the need of using prolonged 
electrocardiography monitoring so that increasing the 
diagnosis sensibility and specificity. For this reason, 
loop memory internal and external event monitors (loop 
recorders) had gained relevance.(7) Implantable monitors 
have a memory that can store electrocardiographic 
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tracing of up to 40 minutes before activations and 2 
minutes after it. These monitors can be easily implanted 
in the under patients’ skin and its battery last for 15 to 18 
months.(8) Therefore, implantable monitor is the most 
precisely way to investigate patients with infrequent 
symptoms (intervals between events greater than 1 
month), and also because it presents more accuracy in 
the diagnosis for its monitoring for longer time periods. 
However, implantable devices have a higher cost and 
need a surgical procedure for implantation. In addition, 
post-operatory period can cause pain, risk of infection, 
and negative aesthetic issues in the implanted site. 
External monitor, however, has disadvantages such 
as the need of electrodes attached to the skin that might 
cause irritation and need of discontinuity monitoring. 
Unfortunately, these monitors still not able to detect 
events automatically and they need to be activated by 
the patient or his/her caregiver when symptoms occur. 
This type of monitor constitutes a non-invasive method, 
less expensive and can be a cost-effective option mainly 
in those patients with low frequency of symptoms 
(weekly or monthly intervals between episodes). 
In our study population we observed in 66% of 
patients with external event monitor, web-loop type 
monitor, the device was able to clarify arrhythmic 
symptoms, which is a result similar to data found in the 
literature using other types of event monitors.(9) For 
palpitations the accuracy of diagnosis ranged between 
66% and 75%, which is higher than the efficacy of the 
24-hours Holter.(10) And, to clarify symptoms of syncope 
and pre-syncope, the accuracy of external event monitor 
is low – about 25%. However, implantable event monitor 
is able to clarify between 35% and 88% of inexplicable 
syncope.(11) Data found in our study reinforce that 
web-loop type monitor is useful to clarify symptoms of 
palpitations, but to clarify medical pictures of syncope, 
mainly those of sporadic occurrence, the implantable 
monitor seems to be more adequate.
Arrhythmias most often detected using the external 
event monitor were ventricular and supraventricular 
extrasystoles followed by supraventricular tachycardia. 
These findings agree with finding in studies with low-risk 
population.(10) The fact that web-loop detected significant 
arrhythmias in patients who did not have arrhythmic 
symptoms raised our attention, and cases detected 
represented 9.8% of those investigated. Although web-
loop was designed to detected symptomatic events, its 
transmission of random tracing automatically might 
be contributed for this finding. Such data suggest this 
method can have an important role in the diagnosis of 
asymptomatic arrhythmias, mainly in clinical pictures 
of paroxysmal atrial fibrillation - an arrhythmia that 
is associated with thromboembolic events.(12) The 
improvement of web-loop by installation of mechanisms 
to detect automatically tachyarrhythmias would contribute 
for such indication. 
In our study with patients submitted to heart rhythm 
monitoring by monitoring of events, symptoms of 
palpitations, pre-syncope or syncope were not associated 
to greater detection of significant arrhythmias. However, 
presence of symptoms in the absence of heart rhythm 
changes constituted useful clinical tool to exclude the 
possible cause of arrhythmia as an etiology of symptoms 
so that supporting the patient’s clinical management. 
External event monitor is useful to record ECG during 
arrhythmic symptoms and, although there is no high 
detection of atrial, ventricular tachyarrhythmias or 
atrioventricular blocks, the fact of recording the absence 
of arrhythmia is relevant and helps to guide the patient 
concerning the benign of his/her symptoms, and in this 
way to avoid the use of antiarrhythmic drugs or the need 
of invasive procedures to elucidate diagnostic symptoms. 
This study is limited by the use of a retrospective 
designed based on collection of information which were 
recorded during exams (electrocardiographic tracing 
obtained and simplified questionnaires completed by 
patients just before monitoring begins). For this reason, 
relevant clinical information, e.g., presence of structural 
hearth disease, use of antiarrhythmic drugs and history 
of psychiatric disease were not adequate documented. 
Therefore, to conduct a multivariate analysis adjusted 
to results was not possible. These information should be 
included in an future prospective study. 
CONCLUSION
The use of external event monitor, web-loop type 
monitor, did not show association between presence 
of specific symptoms and detection of significant 
arrhythmias in the studied population. This method of 
diagnosis seems to be importance to elucidate symptoms, 
especially, in case of no change in heart rhythm. External 
event monitoring constitutes useful clinical tool to exclude 
possible arrhythmia as etiology. 
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